1-hydroxymethylmidazolam has been researched along with digoxin in 3 studies
Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (digoxin) | Trials (digoxin) | Recent Studies (post-2010) (digoxin) |
---|---|---|---|---|---|
163 | 46 | 49 | 11,483 | 958 | 1,289 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, K; Hamahata, Y; Hayashi, M; Iwanaga, K; Kakemi, M; Miyazaki, M; Shibano, M; Taniguchi, M | 1 |
Bi, H; Huang, L; Huang, M; Qin, X; Xiao, H; Xue, X; Zhong, G | 1 |
Alves, K; Chandorkar, G; Farmer, HF; Garg, V; Smith, F; van Heeswijk, RP | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and digoxin
Article | Year |
---|---|
Effect of telaprevir on the pharmacokinetics of midazolam and digoxin.
Topics: Adolescent; Adult; Antiviral Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Drug Interactions; Female; Humans; Male; Midazolam; Middle Aged; Oligopeptides; Protease Inhibitors; Young Adult | 2012 |
2 other study(ies) available for 1-hydroxymethylmidazolam and digoxin
Article | Year |
---|---|
Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
Topics: Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Digoxin; Furocoumarins; Humans; Medicine, Kampo; Midazolam; Quinidine | 2010 |
Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Calibration; Cardiotonic Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Digoxin; Drug Interactions; Drug Stability; Limit of Detection; Male; Midazolam; Random Allocation; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |